Drug Pipeline

CBL-514 Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Phase 3

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-05	NCT07608770 A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for…	Recruitment opened

New Trial Filings, Last 30 Days

First Posted	Trial	Phase	Status
2026-05-27	NCT07608757 A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for…	Phase 2	Not Yet Recruiting
2026-05-27	NCT07608770 A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for…	Phase 2	Recruiting

Active Studies by Phase

Phase 3

Phase 2

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT07140939	A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing…	Subcutaneous Fat	Not Yet Recruiting
NCT07526974	A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing…	Subcutaneous Fat	Not Yet Recruiting
Phase 2
NCT07608770	A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for…	Subcutaneous Fat	Recruiting
NCT06303570	A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in…	Dercum's Disease	Active, Not Recruiting
NCT07608757	A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for…	Subcutaneous Fat	Not Yet Recruiting

Sponsors Running CBL-514 Injection Trials

Caliway Biopharmaceuticals Co., Ltd. (5)

Get alerts when CBL-514 Injection trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.